Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-049650

Chief Financial Officer sold 10,000 shares at an average $180.38 ($1,803,821)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McAnear Justin J. · Chief Financial Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-02 Exercise or conversion : show line 1 in the form +10,000 $5.04 $50,400 49,370 D
2021-08-02 Sale : show line 2 in the form −1,698 $178.35 $302,840 47,672 D
2021-08-02 Sale : show line 3 in the form −2,202 $179.28 $394,780 45,470 D
2021-08-02 Sale : show line 4 in the form −2,298 $180.29 $414,304 43,172 D
2021-08-02 Sale : show line 5 in the form −2,302 $181.31 $417,376 40,870 D
2021-08-02 Sale : show line 6 in the form −700 $182.16 $127,514 40,170 D
2021-08-02 Sale : show line 7 in the form −500 $183.30 $91,650 39,670 D
2021-08-02 Sale : show line 8 in the form −300 $184.52 $55,357 39,370 D
Open-market sales · 10,000 sh · avg $180.38 · $1,803,821

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-08-02 Exercise or conversion : show line 9 in the form Stock Option (right to buy) −10,000 $5.04 2028-11-02 10,000 400,159 D
Loading xslF345X03/doc4.xml…